Short-term results of the Ascension pyrolytic carbon metacarpophalangeal joint replacement arthroplasty for osteoarthritis.
BACKGROUND
Osteoarthritis of the metacarpophalangeal joints is difficult to manage due to the high demands placed on any prosthesis. We report the preliminary results of our experience using the Ascension pyrolytic carbon implant.


METHODS
A pyrocarbon metacarpophalangeal joint replacement was implanted into seven patients (10 metacarpophalangeal joints) with osteoarthritis. Patients were reviewed both clinically and radiologically.


RESULTS
At a mean follow-up of 2.2 years (1-4 years) there were no implant failures nor loosenings. Pain scores improved from 68% to 3% postoperatively, and there was a very high rate of patient satisfaction.


CONCLUSIONS
Pyrocarbon implants are a promising solution to a condition which may be otherwise difficult to treat surgically.
Nuñez
V A
VA
Hand Unit, Nelson Hospital, Kingston Road, London SW20 8DB, UK.
Citron
N D
ND
D000368:Aged; D001672:Biocompatible Materials; D002244:Carbon; D005260:Female; D005500:Follow-Up Studies; D018737:Hand Strength; D006801:Humans; D007595:Joint Prosthesis; D008297:Male; D008662:Metacarpophalangeal Joint / Q000601:surgery*; D008875:Middle Aged; D010003:Osteoarthritis / Q000601:surgery*; D010147:Pain Measurement; D016896:Treatment Outcome
D001672:Biocompatible Materials; C009139:pyrolytic carbon; D002244:Carbon